• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

塞尔维亚萨玛迪亚地区多发性硬化症的流行情况。

Prevalence of multiple sclerosis in the Serbian district Sumadija.

机构信息

Clinic of Neurology, Clinical Center Kragujevac, Faculty of Medicine, University of Kragujevac, Kragujevac, Serbia.

出版信息

Neuroepidemiology. 2011;37(2):102-6. doi: 10.1159/000330836. Epub 2011 Sep 15.

DOI:10.1159/000330836
PMID:21921643
Abstract

BACKGROUND

The aim of this study was to estimate the prevalence of multiple sclerosis (MS) in the district of Sumadija (central part of Serbia).

METHODS

All persons suffering from MS, with permanent residence in the region, were recruited. Prevalence was calculated on December 31, 2006, according to a standard procedure.

RESULTS

On December 31, 2006, one hundred ninety-four patients (72 males and 122 females) were found to have MS. We found a crude MS prevalence of 64.9/100,000 (49.3/100,000 for males and 79.9/ 100,000 for females). The highest prevalence rates were registered in the age group of 30-39 years for females and 40-49 years for males, although the age-specific rates were higher in females in all age groups. The mean age at onset was 34.2 ± 9.3 years. The average duration of MS was 8.9 ± 6.2 years. The median EDSS score was 3.9 ± 2.0. The course of MS was relapsing-remitting in 63.9% of patients, secondary progressive in 32.5%, and primary progressive in 3.6%. At MS onset, motor symptoms were present in 70.1% of patients, sensory in 40.7%, cerebellar in 21.1%, brainstem in 15.5%, visual in 22.2%, and bowel/bladder disturbances in 22.2%.

CONCLUSIONS

Our results demonstrate that the MS prevalence registered in the Serbian district Sumadija is similar to that of other surrounding areas in Southeastern Europe.

摘要

背景

本研究旨在评估塞尔维亚中部苏马迪加地区多发性硬化症(MS)的患病率。

方法

招募所有在该地区有常住居民身份且患有 MS 的人。患病率是根据标准程序于 2006 年 12 月 31 日计算的。

结果

截至 2006 年 12 月 31 日,共发现 194 名患者(72 名男性和 122 名女性)患有 MS。我们发现 MS 的粗患病率为 64.9/100,000(男性为 49.3/100,000,女性为 79.9/100,000)。女性的患病率在 30-39 岁年龄组和男性的 40-49 岁年龄组最高,但在所有年龄组中,女性的年龄特异性患病率更高。发病平均年龄为 34.2 ± 9.3 岁。MS 的平均病程为 8.9 ± 6.2 年。平均 EDSS 评分为 3.9 ± 2.0。MS 的病程在 63.9%的患者中为复发缓解型,在 32.5%的患者中为继发进展型,在 3.6%的患者中为原发进展型。在 MS 发病时,70.1%的患者有运动症状,40.7%的患者有感觉症状,21.1%的患者有小脑症状,15.5%的患者有脑干症状,22.2%的患者有视觉症状,22.2%的患者有肠/膀胱功能障碍。

结论

我们的结果表明,塞尔维亚苏马迪加地区登记的 MS 患病率与东南欧其他周边地区相似。

相似文献

1
Prevalence of multiple sclerosis in the Serbian district Sumadija.塞尔维亚萨玛迪亚地区多发性硬化症的流行情况。
Neuroepidemiology. 2011;37(2):102-6. doi: 10.1159/000330836. Epub 2011 Sep 15.
2
A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study.伊朗德黑兰多发性硬化症的 20 年发病趋势(1989-2008 年)和时点患病率(2009 年 3 月 20 日):一项基于人群的研究。
Neuroepidemiology. 2011;36(3):141-7. doi: 10.1159/000324708. Epub 2011 Apr 20.
3
Epidemiology of multiple sclerosis in western Herzegovina.黑塞哥维那西部多发性硬化症的流行病学
Clin Neurol Neurosurg. 2007 Nov;109(9):779-83. doi: 10.1016/j.clineuro.2007.07.014. Epub 2007 Sep 4.
4
Prevalence of multiple sclerosis door-to-door survey in Maltepe, Istanbul, Turkey.土耳其伊斯坦布尔马尔泰佩多发性硬化症挨家挨户调查的患病率
Neuroepidemiology. 2006;27(1):17-21. doi: 10.1159/000093895. Epub 2006 Jun 13.
5
Epidemiology of Charcot-Marie-Tooth disease in the population of Belgrade, Serbia.塞尔维亚贝尔格莱德人群中的夏科-马里-图什病的流行病学。
Neuroepidemiology. 2011;36(3):177-82. doi: 10.1159/000327029. Epub 2011 May 5.
6
Clinical characteristics of multiple sclerosis in Lebanon.黎巴嫩多发性硬化症的临床特征
J Neurol Sci. 2008 Jul 15;270(1-2):88-93. doi: 10.1016/j.jns.2008.02.009. Epub 2008 Mar 25.
7
Epidemiology of multiple sclerosis in western Herzegovina and Herzegovina--Neretva Canton, Bosnia and Herzegovina.波斯尼亚和黑塞哥维那西部黑塞哥维那及黑塞哥维那-内雷特瓦州的多发性硬化症流行病学
Coll Antropol. 2010 Mar;34 Suppl 1:189-93.
8
Multiple sclerosis in Iraq: does it have the same features encountered in Western countries?伊拉克的多发性硬化症:它具有西方国家所遇到的相同特征吗?
J Neurol Sci. 2005 Jul 15;234(1-2):67-71. doi: 10.1016/j.jns.2005.03.033.
9
[Clinical-epidemiological characteristics of late onset multiple sclerosis].[迟发性多发性硬化的临床流行病学特征]
Rev Neurol. 1997 Dec;25(148):1863-6.
10
[Epidemiology and clinical evolutionary aspects of multiple sclerosis in Navarra].[纳瓦拉多发性硬化症的流行病学及临床演变情况]
Neurologia. 1991 May;6(5):160-9.

引用本文的文献

1
Prevalence and incidence of multiple sclerosis in Bulgaria.保加利亚多发性硬化症的患病率和发病率。
Front Neurol. 2025 Mar 18;16:1513390. doi: 10.3389/fneur.2025.1513390. eCollection 2025.
2
Determination of systemic inflammatory biomarkers in multiple sclerosis.多发性硬化症中全身炎症生物标志物的测定。
J Med Biochem. 2024 Apr 23;43(2):257-264. doi: 10.5937/jomb0-45083.
3
Clinical characteristics and dynamics of disability progression in a cohort of patients with multiple sclerosis in Latvians.拉脱维亚多发性硬化症患者队列的临床特征及残疾进展动态
Neurol Sci. 2024 Jul;45(7):3347-3358. doi: 10.1007/s10072-024-07404-z. Epub 2024 Feb 23.
4
Oxidative stress-related risk of the multiple sclerosis development.氧化应激相关的多发性硬化症发病风险。
J Med Biochem. 2023 Jan 20;42(1):1-8. doi: 10.5937/jomb0-37546.
5
Systematic literature review and meta-analysis of the prevalence of secondary progressive multiple sclerosis in the USA, Europe, Canada, Australia, and Brazil.系统文献回顾和荟萃分析美国、欧洲、加拿大、澳大利亚和巴西的继发进展性多发性硬化症的患病率。
BMC Neurol. 2022 Aug 17;22(1):301. doi: 10.1186/s12883-022-02820-0.
6
Epidemiological characteristics and functional disability of multiple sclerosis patients in kosovo.科索沃多发性硬化症患者的流行病学特征及功能残疾情况
Med Arch. 2014 Jun;68(3):178-81. doi: 10.5455/medarh.2014.68.178-181. Epub 2014 May 31.